Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENSC Ensysce Biosciences Inc.

盘前交易 05-03 06:56:47 EDT

0.5690

-0.0390

-6.41%

最高0.6088	最低0.5350	成交量9.95万
今开0.6088	昨收0.6080	日振幅12.14%
总市值431.60万	流通市值421.01万	总股本758.52万
成交额5.64万	换手率1.34%	流通股本739.92万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.569,"timestamp":1714680000000,"preClose":0.608,"halted":0,"volume":99489,"delay":0,"floatShares":7399191,"shares":7585172,"eps":-4.693343,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.039,"latestTime":"05-03 06:56:47 EDT","open":0.6088,"high":0.6088,"low":0.535,"amount":56442.9650343,"amplitude":0.121382,"askPrice":0.7766,"askSize":100,"bidPrice":0.52,"bidSize":199,"shortable":0,"etf":0,"ttmEps":-4.693343,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714743000000},"adr":0,"adjPreClose":0.569,"postHourTrading":{"tag":"盘后","latestPrice":0.5948,"preClose":0.569,"latestTime":"19:53 EDT","volume":7869,"amount":4341.27,"timestamp":1714694039685},"volumeRatio":1.2209246673686225},"requestUrl":"/m/hq/s/ENSC","defaultTab":"news","newsList":[{"id":"2432017306","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432017306","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432017306?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:37","pubTimestamp":1714657022,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时37分，Ensysce Biosciences, Inc.股票出现波动，股价快速跳水6.20%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Allarity Therapeutics, Inc.、Context Therapeutics Inc.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为1888.50%、320.30%、89.12%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为50.36%、22.07%、21.42%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022137028b6d2ccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022137028b6d2ccc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431860628","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.27%报0.615美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431860628","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431860628?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:37","pubTimestamp":1714401436,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时37分，Ensysce Biosciences, Inc.股票出现波动，股价急速拉升5.27%。截至发稿，该股报0.615美元/股，成交量4298股，换手率0.06%，振幅2.14%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292237167924f6ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292237167924f6ee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430348270","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨7.92%报0.590美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430348270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430348270?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:32","pubTimestamp":1714138324,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时32分，Ensysce Biosciences, Inc.股票出现波动，股价急速拉升7.92%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、Tevogen Bio Holdings Inc.、Cassava Sciences Inc C/Wts 15/11/2024涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为530.97%、68.25%、20.44%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Biodexa Pharmaceuticals Plc、Allarity Therapeutics, Inc.，振幅分别为34.80%、23.45%、18.81%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262132048b577b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262132048b577b18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429973939","title":"Ensysce Biosciences, Inc.盘中异动 急速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429973939","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429973939?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:20","pubTimestamp":1713799210,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时20分，Ensysce Biosciences, Inc.股票出现异动，股价快速下跌5.25%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Nkgen Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为181.26%、66.85%、58.04%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech, Inc.，振幅分别为247.52%、82.14%、35.26%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222320107a549bca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222320107a549bca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428697056","title":"Ensysce Biosciences, Inc.盘中异动 大幅跳水8.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428697056","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428697056?lang=zh_cn&edition=full","pubTime":"2024-04-20 00:21","pubTimestamp":1713543660,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日00时21分，Ensysce Biosciences, Inc.股票出现波动，股价急速下挫8.65%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为220.52%、12.85%、11.09%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Chromocell Therapeutics Corporation、Brainstorm Cell Therapeutics Inc.，振幅分别为46.41%、34.28%、30.47%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420002100879675c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420002100879675c0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428451463","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨5.31%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428451463","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428451463?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360661,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速上涨5.31%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Novabay Pharmaceuticals, Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.12%、21.89%、16.22%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Rani Therapeutics Holdings, Inc.、Vanda Pharmaceuticals Inc.，振幅分别为16.09%、11.06%、10.12%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131018b2ffb85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172131018b2ffb85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427796748","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌5.52%报0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427796748","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427796748?lang=zh_cn&edition=full","pubTime":"2024-04-16 23:05","pubTimestamp":1713279949,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日23时05分，Ensysce Biosciences, Inc.股票出现波动，股价急速跳水5.52%。截至发稿，该股报0.642美元/股，成交量2.5972万股，换手率0.35%，振幅2.93%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162305497a533099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162305497a533099&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427913006","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌6.03%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427913006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427913006?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:38","pubTimestamp":1713188309,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时38分，Ensysce Biosciences, Inc.股票出现异动，股价大幅下挫6.03%。截至发稿，该股报0.700美元/股，成交量2.9861万股，换手率0.41%，振幅4.03%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213829861e5ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213829861e5ce8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426264478","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌5.28%报0.741美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426264478","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426264478?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:37","pubTimestamp":1712849821,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时37分，Ensysce Biosciences, Inc.股票出现异动，股价快速下跌5.28%。截至发稿，该股报0.741美元/股，成交量4.2881万股，换手率0.59%，振幅2.30%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411233701791ff48f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411233701791ff48f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425891320","title":"Ensysce Biosciences, Inc.盘中异动 快速跳水6.58%报0.752美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425891320","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425891320?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:59","pubTimestamp":1712584778,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时59分，Ensysce Biosciences, Inc.股票出现异动，股价快速下挫6.58%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Longeveron Inc.、阿诺医药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Longeveron Inc.、Allarity Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为981.86%、699.48%、53.82%，振幅较大的相关个股有Longeveron Inc.、阿诺医药、Renovorx, Inc.，振幅分别为103.99%、28.70%、25.11%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082159387a51674c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082159387a51674c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425310689","title":"Ensysce Biosciences, Inc.盘中异动 大幅上涨5.00%报0.843美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425310689","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425310689?lang=zh_cn&edition=full","pubTime":"2024-04-05 00:53","pubTimestamp":1712249596,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日00时53分，Ensysce Biosciences, Inc.股票出现异动，股价大幅上涨5.00%。截至发稿，该股报0.843美元/股，成交量9.4704万股，换手率1.29%，振幅4.54%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405005316791eced4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405005316791eced4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420785478","title":"Ensysce 生物科学公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2420785478","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420785478?lang=zh_cn&edition=full","pubTime":"2024-03-20 05:02","pubTimestamp":1710882148,"startTime":"0","endTime":"0","summary":"   * Ensysce Biosciences Inc   报告，截至12月底的季度调整后每股亏损1.37美元，高于去年同期的每股收益18.24美元。三位分析师对该季度的平均预期是每股亏损 87 美分。华尔街预期为每股-93美分至-81美分。* 收入为 51.503 万美元，同比下降 64.1%；分析师预期为 39.50 万美元。* Ensysce Biosciences Inc 公布的本季度每股收益为亏损 1.37 美元。* Ensysce Biosciences Inc 本季度股价下跌了 23.6%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Ensysce Biosciences Inc 的 12 个月目标价中位数为 16.30 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420153226","title":"Ensysce Biosciences Inc   预计每股亏损93美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420153226","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420153226?lang=zh_cn&edition=full","pubTime":"2024-03-19 20:42","pubTimestamp":1710852159,"startTime":"0","endTime":"0","summary":"   * Ensysce Biosciences Inc    将于3月21日公布截至2024年3月31日的季度财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于加利福尼亚州拉霍亚的公司的营收将从一年前的79万美元下降49.4%，至40万美元。* LSEG 的分析师平均预计 Ensysce Biosciences Inc 每股亏损 93 美分。* 华尔街对 Ensysce Biosciences Inc 的 12 个月目标价中位数为 16.30 美元，高于其 0.81 美元的最新收盘价。3月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420147145","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420147145","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420147145?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:30","pubTimestamp":1710768642,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时30分，Ensysce Biosciences, Inc.股票出现波动，股价急速上涨7.11%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Elicio Therapeutics, Inc.、Galera Therapeutics, Inc.、Xtl生物制药涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为57.41%、11.42%、6.08%，振幅较大的相关个股有Quince Therapeutics, Inc.、Scorpius Holdings, Inc.、Turnstone Biologics Corp.，振幅分别为7.76%、6.19%、6.02%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213042861df163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318213042861df163&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419318050","title":"Ensysce Biosciences Inc   预计每股亏损93美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2419318050","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419318050?lang=zh_cn&edition=full","pubTime":"2024-03-16 04:40","pubTimestamp":1710535216,"startTime":"0","endTime":"0","summary":"   * Ensysce Biosciences Inc    将于3月21日公布截至2024年3月31日的季度财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于加利福尼亚州拉霍亚的公司的营收预计将从一年前的79万美元下降68.4%至25万美元。* LSEG 分析师对 Ensysce Biosciences Inc 的平均预期是每股亏损 93 美分。* 华尔街对 Ensysce Biosciences Inc 的 12 个月目标价中位数为 16.30 美元，高于其 0.75 美元的最新收盘价。3月15日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ensysce.com","stockEarnings":[{"period":"1week","weight":0.0408},{"period":"1month","weight":-0.2975},{"period":"3month","weight":-0.6305},{"period":"6month","weight":-0.4253},{"period":"1year","weight":-0.847},{"period":"ytd","weight":-0.4632}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台，该公司正在开发一类新的强大、防篡改的阿片类药物，可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛，并有助于预防阿片类药物滥用造成的死亡，从而降低人力和经济成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.026078},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.1585},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.046294},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.084407},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.106758},{"month":6,"riseRate":0.833333,"avgChangeRate":0.07296},{"month":7,"riseRate":0.5,"avgChangeRate":-0.165728},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.117139},{"month":9,"riseRate":0.5,"avgChangeRate":-0.125873},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.140061},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.017964},{"month":12,"riseRate":0.666667,"avgChangeRate":0.215166}],"exchange":"NASDAQ","name":"Ensysce Biosciences Inc.","nameEN":"Ensysce Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ensysce Biosciences Inc.,ENSC,Ensysce Biosciences Inc.股票,Ensysce Biosciences Inc.股票老虎,Ensysce Biosciences Inc.股票老虎国际,Ensysce Biosciences Inc.行情,Ensysce Biosciences Inc.股票行情,Ensysce Biosciences Inc.股价,Ensysce Biosciences Inc.股市,Ensysce Biosciences Inc.股票价格,Ensysce Biosciences Inc.股票交易,Ensysce Biosciences Inc.股票购买,Ensysce Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况